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Article 5

A Hidden Side of Norplant
by
Kristine M. Severyn, R.Ph., Ph.D.

The author received her Ph.D. in biopharmaceutics from the University of
Cincinnati College of Pharmacy. She is a certified teacher of National Family
Planning. She lives in Dayton, Ohio with her husband and three children.
On December 6, 1990 USA Today proclaimed the soon to be licensed
NORPLANT contraceptive implant, "As perfect a method as you can have."l
Three years later the Chicago Tribune headline read, "No panacea: Norplant suit
charges failure to educate patients."2 What happened during this time to dampen
the initial enthusiasm for Norplant?
What is Norplant?

~
I

The "NORPLANT SYSTEM" is a birth control method involving the surgical
insertion of six flexible match stick size rods of Silastic into the inner upper arm of
women. The rods (implants) contain levonorgestrel, a progesterone type drug,
which is released slowly to prevent pregnancy for up to five years. 3
Levonorgestrel and its chemical relative norgestrel have been components of
oral contraceptives ("birth control pills") for several years.4 Since Norplant does
not contain estrogen, which is associated with blood clotting and cardiovascular
disorders5,6, the manufacturer promotes Norplant " ... as a particularly good
option for a woman who ... wants a form of hormonal contraception but does
not wish to use estrogen-containing contraceptives."7
How Is Norplant Inserted?

After the woman lies on the doctor's examining table, and her upper inside
arm prepared with antispetic, she receives six injections of local anesthetic "to
mimic the fanlike position of the implanted capsules." Next, a scalpel is used to
cut a 2mm shallow incision in the woman's arm. Through this incision is inserted
a large-bore needle, and the six implants placed through this needle under the
skin in a fan shape. "Correct and carefully performed subdermal insertion of the
six capsules" is important because "failure to do so may result in deep placement .
. . and could make removal more difficult." After three days, keeping the wound
clean and dry, she may resume normal activities. A typical insertion procedure
takes about fifteen minutes. 3
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What Are the Side Effects of Norplant?
Nearly all women on Norplant experience changes in menstrual patterns,
ranging from excessive bleeding, spotting, or total absence of periods. Women
are warned that this irregular bleeding could "mask symptoms of cervical or
endometrial cancer." Common adverse reactions during the first year include:
headache, nervousness, nausea, dizziness, dermatitis (skin inflammation), acne,
change of appetite, mastalgia (painful breasts), weight gain, hirsutism (excessive
hair growth), hypertrichosis (facial hair), and scalp hair loss.
Other Possible adverse reactions include breast discharge, cervicitis
(inflammation of the cervix), musculoskeletal pain, abdominal discomfort,
leukorrhea (white vaginal discharge), and vaginitis (vaginal inflammation).
"Warnings" and "Precautions" include the following: delayed follicular atresia
(ovarian follicles do not reduce in size after ovulation; may require surgical
correction); ectopic pregnancy (risk may increase the longer Norplant is used);
caution ifbreastfeeding; foreign body carcinogenesis (cancer); thromboembolic
(blood clotting) disorders; caution in smokers; possibility of elevated blood
pressure; myocardial infarction (heart attack); carcinoma (cancer of the breast,
uterus, ovaries, or cervix); hepatic (liver) tumors; ocular (eye) lesions; gallbladder
disease; possible changes in carbohydrate metabolism (may complicate
diabetes); hyperlipidemia (high blood fat concentration); liver function (jaundice
may develop); fluid retention; emotional disorders; visual changes with contact
lenses.3
Although several or none of the above adverse effects may occur in any
particular woman, drug company lawyers use similar lists in the manufacturer's
"Package Insert" as a defense when these companies are sued by recipients of
drugs or vaccines. 8 • and others.
To stern the high incidence of Norplant side effects 9-11, it was suggested to give
estrodiol (an estrogen-type drug; 12,13) or oral contraceptives l4 to reduce the
duration of excessive bleeding caused by Norplant. It is ironic that Norplant is
advertised as containing no estrogen, but that estrogen-containing products are
recommended to remedy Norplant's side effects.

How Effective Is Norplant?
Norplant's effectiveness in preventing pregnancy is in the same range as male
or female sterilization.3 However, this high efficacy (0.2 pregnancies per 100
women for five years of N orplant use) only applies to women who weigh less than
110 pounds. For women weighing 110-130 pounds, the five year pregnancy rate
rises to 3.4 (per 100 women using the method for five years), and to 5.0 for
women weighing between 131-153 pounds. For larger women (weighing more
than 154 pounds) the five-year cumulative pregnancy rate rises to 8.5 ,(per 100
women). Based on these rates the manufacturer is careful to state that Norplant
provides "up to" five years of contraception. 3

How Does Norplant Prevent Pregnancy?
Norplant uses several mechanisms to prevent pregnancy. First, the hormone in
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Norplant inhibits ovulation in about half of cycles, with a trend toward less
ovulation in the first year of Nor plant use, and more in the later life of the implant
(cycles inhibited: 20 to 75%15; 59%16; 40 to 86%17; 67%18). In cycles where
ovulation occurs, less progesterone is produced after ovulation in Norplant
users I5 ,16,18 resulting in luteal phase defects, this phase being important for
implantation of a fertilized ovum, and for the early pregnancy to be maintained.
Norplant also changes the quality of cervical mucus, making it thick and hostile
to sperm migration, thereby reducing the possibility that sperm and ovum will
unite. 16 ,19
Last! y, Norplant causes growth of the endometrium (inner lining ofthe uterus)
to be suppressed, resulting in its inability to support implantation of a fertilized
ovum, the new human life.20 Although this latter researcher states, "The actual
role of these endometrial alterations in the overall contraceptive effect of
Norplant .. . is difficult to assess .. .," others deny that this abortifacient action
plays any role in the overall mechanism of Norplant. However they acknowledge
that an early pregnancy would be easy to miss due to the irregular bleeding
patterns of Norplant users l8 , or the lack of sensitivity of the blood test used to
detect hCG during the first five days after fertilization 21 (hCG=human chorionic
gonadotropin; produced by the fertilized ovum in early stages of pregnancy).
Since pregnancy occurs in a small number of women on Norplant I8,21, it is
obvious that these back-up contraceptive mechanisms are not always operative.

Norplant Use In Teens
Despite the lack of pre-license testing of Norplant in those under 18 years of
age to determine safety and efficacy in this age group22, teen use of Norplant has
been advocated.14,23 Planned Parenthood clinics require no parental consent
before Norplant insertion 24, their attorneys determining that when implants are
inserted through the large-bore needle poked directly through the skin, bypassing
the small incision, "the procedure is not legally . .. surgery ... and nullifies
requirements for parental consent".23
In January 1993 a Baltimore public school for pregnant girls, or girls already
with babies, began to perform Norplant insertions at its health clinic, with more
schools expected to follow .25,26 Except for rare dissent based on moral or racial
objections 27,28, the press has basically supported the policy, with concerns
expressed only about Norplant's failure to protect users from sexually transmitted
diseases (STD), including AIDS.29-31 These concerns are valid, based on the high
rate of gonorrhea infection in teen-age girls as compared to older women. 32
Cost of Norplant

Norplant can cost up to $700, which includes purchase price of the implant and
physician charges for insertion and removal. Medicaid pays the cost of Nor plant
in all fifty states for women on welfare. 33 For those not eligible for Medicaid, i.e.,
"working poor," Maryland budgeted $1 million for Norplant and Depo-Provera
(a 3-month injectable birth control drug), with an unexpected high demand for
these products during the first three months of the state's program. 34
For indigent women living in other states, Norplant's manufacturer established
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The Norplant Foundation, described as "a charitable, non-profit foundation
committed to improving voluntary access to Norplant for American women."
Eligibility is based on annual income, lack of insurance coverage for
contraception, and a physician willing to waive the insertion and removal
fees.35,36
Although the initial cost of Norplant to U.S. women approaches $700, the
annualized (per year) costs of Norplant may be significantly higher in some
women. With a first year removal rate in the range of 20%, many women do
not achieve the five years of contraception promoted to them by Wyeth. With
the costs of difficult surgical removal of the implant, or administration of
additional drugs, e.g., estrogens or combination oral contraceptives, to remedy
Norplant side effects 12-14, the yearly cost of Norplant may actually surpass that
of oral contraceptives. These hidden costs are not factored into Wyeth's
idealized cost estimates for Norplant use. 33

Coercive and Deceptive Use of Norplant
Less than one month after Norplant's U.S. licensing a California judge
sentenced a 27-year-old pregnant mother of four children to have the birth
control rods implanted as part of a criminal sentence for beating two of her
children. 37 Three months after the sentence this judge, who prided himself on
"creative sentencing"38, removed himselffrom the case due to the nationwide
attention, including an American Civil Liberties Union supported appeal,39-46
Later that year a Texasjudge ordered a 23-year-old woman to use Norplant
after her baby was born with methad'one in his blood.47
This sort of "creative sentencing" prompted several state legislatures to
discuss financial incentives for women on welfare to use Norplant, or make
welfare contingent on Norplant use.48 -53 A bill was even introduced in Ohio
which would have required Norplant or tubal ligation for women, or
vasectomy for men, if the family had a child and received welfare benefits for
their support. Parents would have faced jail for refusing sterilization or
Norplant. 54
The American Medical Association decried this government pressure,
stating, "Court-ordered use of long-acting contraceptives ... raises serious
questions about a person's fundamental right to refuse medical treatment, to be
free of cruel and unusual punishment, and to procreate." The AMA also
asserted, "Government benefits should not be made contingent on the
acceptance of a health risk."55
This U.S. coercion reflects several foreign pre-licensing studies, where
women were not properly warned of Norplant-associated risks, or were refused
removal of the rods when requested.56-59
Concerns were also expressed that Indonesian medical authorities do not
know the identities of women with Norplant who are due for its removal. The
chance of ectopic pregnancy is reported to increase if the rods are not removed
after five years, resulting in possible Fallopian tube rupture with potential fatal
internal hemorrhage. These women are called "walking time bombs," because
many live in remote areas lacking medical care.60
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Difficulty in Norplant Removal and Class Action Lawsuit

As expected, based on experience with other contraceptives,61 a class action
lawsuit was filed September 13, 1993 in Illinois on behalf of women severely or
permanently injured by Norplant. The amended complaint, filed on November
5, 1993, alleges that the manufacturer failed to warn "about the difficulty of
(NORPLANT) removal," and as a result, women " ... were damaged . .. and ...
will require continuing medical care due . . . to the difficulty with removal of
Norplant."62
The complaint details the unfavorable experiences of four women with
Norplant. One woman suffered "interrupted and/or heavy and continual
menstrual flow, nausea, weight gain (20 pounds), and severe headaches." Sixteen
months after Norplant insertion, the physician, who unsuccessfully attempted to
remove the rods, closed the incision and told her to return again. Three months
later, and after two additional failed attempts to remove the rods, she was forced
"to undergo surgery, under a general anesthetic .. . to remove the Norplant
implants," and now "has severe scarring ... "
A second woman gained eighteen pounds, developed menstrual irregularities,
excessive hair growth, acne, and emotional side effects (irritability) during her
thirteen-month use of Norplant. The more than two-hour implant removal
surgery required two separate incisions. Her arm was "bruised and sore," and" ...
left with two ugly scars." She continues to consult a dermatologist for the acne.
During a third woman's seventeen months on Norplant she "experienced
abnormally long menstrual cycles," which progressed to lack of menstrual
cycles," which progressed to lack of menstrual cycles, " .. . hot flashes, headaches,
and a numbness and pain in her left arm" so severe that "she could not pick things
up with her left hand . .. " Although she sought removal of the Norplant rods
fifteen months after insertion, doctors were unsuccessful in removing them, even
after nearly Ilh hours of surgery. Two months later two more surgeons finally
removed the implants through two separate incisions. She now has "severe
scarring" after the two painful removal surgeries.
A fourth woman's Norplant experience included "excessive bleeding for two
weeks" (after insertion), with "nausea, dizziness, weight gain, . .. migraine
headaches, diminished sex drive, (and) ... irritability" for the thirteen months the
Norplant rods were in her body. Four months after insertion she complained to
her doctor about the side effects, and was told twice to wait for two months (an
additional four months). She finally demanded removal of the Norplant rods ten
months after they were inserted.
Dependent on public assistance she was told that the clinic lacked government
funds for Norplant removal, and to wait three more months until the next fiscal
year. During these three months she failed to find a physician who would remove
the implants. When government funds became available, she returned to the
clinic and underwent llh hours of surgery to remove only two of the six implants.
The nexy month she endured three more surgeries, one lasting 3lh hours with
eight injections of anesthetic, yielding removal of only one implant. Another
surgical attempt failed to remove any of the three remaining implants. She was
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referred to a specialist who recommended surgery under general anesthesia.
Nearly five months after asking for Norplant removal, the fourth surgery removed
the remaining three implants. She now has "severe scarring" and arm pain.
The suit accuses Norplant's manufacturer, Wyeth-Ayerst, of nine charges,
induding "negligence" and "consumer fraud ," asks that Wyeth improve its
warnings to women, and devise a "sufficient training program" for those who
insert Norplant. The plaintiffs ask that a compensation fund be established for
these and other women (similar to the funds established several years ago for
women damaged by intrauterine devices 63- 66 and recently proposed for women
damaged by silicone gel breast implants67 ).
Considering that the approximately 800,000 U.S. women who currently use
Norplant will ultimately seek removal of the implants, it is unknown how many
other women will experience problems similar to those in the lawsuit. One could
reasonably expect that the longer the implants are in place, the more difficult they
might be to remove due to adhesions and scar tissue formation. In fact, it has been
recommended that when the implants can not be felt in the woman's arm, or they
migrate to deeper tissues, x-ray or ultrasound be employed to help locate the
Norplant rods. 68
At a 1993 contraception conference a Planned Parenthood physician reported
that insertion of Norplant rods is usually uncomplicated, but some health care
providers have expressed difficulty in removing them. An obstetrics and
gynecology professor recommended use of a curved hemostat to "vigorously
break up" adhesions.69
Conclusion

Three years of use in the United States has uncovered the hidden side of
Norplant. Nearly all Norplant users will experience side effects, forcing early
implant removal in about one-fifth of them during the first year alone. Implant
removal is difficult in some women, possibly involving multiple prolonged
surgical attempts, induding surgery under general anesthesia, leaving unsightly
scars. In addition, Norplant has not proven to be the solution to the moral and
social problem of teenage out-of-wedlock pregnancy, as was predicted, nor does
it protect against STD's. For many women Norplant has been a disappointment,
if not an abject failure.
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